These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 7898035)

  • 1. A refined guinea pig model for evaluating delayed-type hypersensitivity reactions caused by Q fever vaccines.
    Ruble DL; Elliott JJ; Waag DM; Jaax GP
    Lab Anim Sci; 1994 Dec; 44(6):608-12. PubMed ID: 7898035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Q fever cellular and chloroform-methanol residue vaccines as skin test antigens in the sensitized guinea pig.
    Elliott JJ; Ruble DL; Zaucha GM; Jaax GP; Waag DM
    Acta Virol; 1998 Jun; 42(3):147-55. PubMed ID: 9842444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guinea pig abscess/hypersensitivity model for study of adverse vaccination reactions induced by use of Q fever vaccines.
    Wilhelmsen CL; Waag DM
    Comp Med; 2000 Aug; 50(4):374-8. PubMed ID: 11020154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization of dogs with Q fever vaccines: comparison of phase I, II and phase I CMR Coxiella burnetii vaccines.
    Williams JC; Peacock MG; Race RE
    Rev Elev Med Vet Pays Trop; 1993; 46(1-2):87-94. PubMed ID: 8134661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective immunity induced by 67 K outer membrane protein of phase I Coxiella burnetii in mice and guinea pigs.
    Zhang YX; Zhi N; Yu SR; Li QJ; Yu GQ; Zhang X
    Acta Virol; 1994 Dec; 38(6):327-32. PubMed ID: 7793356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenicity of chloroform-methanol-treated Coxiella burnetii preparations.
    Kazár J; Schramek S; Lisák V; Brezina R
    Acta Virol; 1987 Mar; 31(2):158-67. PubMed ID: 2886025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onset and duration of immunity in guinea pigs and mice induced with different Q fever vaccines.
    Kazár J; Votruba D; Propper P; Schramek S
    Acta Virol; 1986 Nov; 30(6):499-506. PubMed ID: 2881470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of adjuvants with Leishmania antigens in a guinea pig model to induce delayed-type hypersensitivity responses.
    Briand EJ; Ruble GR; Stiteler J; Harris LD; Burge JR; Soranaka ET; Glenn G; Quance-Fitch F; Rowton ED
    Lab Anim Sci; 1999 Oct; 49(5):519-21. PubMed ID: 10551453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of a Coxiella burnetii chloroform:methanol residue (CMR) vaccine and a licensed cellular vaccine (Q-Vax) in rodents challenged by aerosol.
    Waag DM; England MJ; Pitt ML
    Vaccine; 1997 Nov; 15(16):1779-83. PubMed ID: 9364683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardized guinea pig model for Q fever vaccine reactogenicity.
    Baeten LA; Podell BK; Sluder AE; Garritsen A; Bowen RA; Poznansky MC
    PLoS One; 2018; 13(10):e0205882. PubMed ID: 30312355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines against coxiellosis and Q fever. Development of a chloroform:methanol residue subunit of phase I Coxiella burnetti for the immunization of animals.
    Williams JC; Peacock MG; Waag DM; Kent G; England MJ; Nelson G; Stephenson EH
    Ann N Y Acad Sci; 1992 Jun; 653():88-111. PubMed ID: 1626897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermal reactions and antibody responses in dairy cows and laboratory animals vaccinated with Coxiella burnetii.
    Biberstein EL; Crenshaw GL; Behymer DE; Franti CE; Bushnell RB; Riemann HP
    Cornell Vet; 1974 Jul; 64(3):387-406. PubMed ID: 4845729
    [No Abstract]   [Full Text] [Related]  

  • 13. Coxiella burnetii Intratracheal Aerosol Infection Model in Mice, Guinea Pigs, and Nonhuman Primates.
    Gregory AE; van Schaik EJ; Russell-Lodrigue KE; Fratzke AP; Samuel JE
    Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31501249
    [No Abstract]   [Full Text] [Related]  

  • 14. Subunit Vaccines Using TLR Triagonist Combination Adjuvants Provide Protection Against
    Fratzke AP; Jan S; Felgner J; Liang L; Nakajima R; Jasinskas A; Manna S; Nihesh FN; Maiti S; Albin TJ; Esser-Kahn AP; Davies DH; Samuel JE; Felgner PL; Gregory AE
    Front Immunol; 2021; 12():653092. PubMed ID: 33815413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermal granulomatous hypersensitivity in Q fever: comparative studies of the granulomatous potential of whole cells of Coxiella burnetii phase I and subfractions.
    Ascher MS; Williams JC; Berman MA
    Infect Immun; 1983 Dec; 42(3):887-9. PubMed ID: 6642669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines against Coxiella infection.
    Zhang G; Samuel JE
    Expert Rev Vaccines; 2004 Oct; 3(5):577-84. PubMed ID: 15485337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced protection against Q fever in BALB/c mice elicited by immunization of chloroform-methanol residue of Coxiella burnetii via intratracheal inoculation.
    Feng J; Hu X; Fu M; Dai L; Yu Y; Luo W; Zhao Z; Lu Z; Du Z; Zhou D; Wen B; Jiao J; Xiong X
    Vaccine; 2019 Sep; 37(41):6076-6084. PubMed ID: 31477436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble antigens derived from
    Gregory AE; van Schaik EJ; Fratzke AP; Russell-Lodrigue KE; Farris CM; Samuel JE
    Cell Rep Med; 2021 Dec; 2(12):100461. PubMed ID: 35028605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy and immunogenicity of Q fever chloroform:methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol.
    Waag DM; England MJ; Tammariello RF; Byrne WR; Gibbs P; Banfield CM; Pitt ML
    Vaccine; 2002 Jun; 20(19-20):2623-34. PubMed ID: 12057622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of Q fever phase I corpuscular vaccine to influence the persistence and reactivation of Coxiella burnetii infection in mouse and guinea pig tissues.
    Kazár J; Kovácová E
    Acta Virol; 1983 Sep; 27(5):418-28. PubMed ID: 6139946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.